Wealthspire Advisors (Maryland)’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
Sell
-308
Closed -$1K 2491
2018
Q4
$1K Hold
308
﹤0.01% 2240
2018
Q3
$2K Hold
308
﹤0.01% 2133
2018
Q2
$2K Hold
308
﹤0.01% 2127
2018
Q1
$11K Hold
308
﹤0.01% 1516
2017
Q4
$13K Hold
308
﹤0.01% 1477
2017
Q3
$13K Hold
308
﹤0.01% 1468
2017
Q2
$11K Hold
308
﹤0.01% 1485
2017
Q1
$17K Buy
+308
New +$17K ﹤0.01% 1141